# A Study of Markers of Glucocorticoid Effects in Patients With Addisons Disease (DOSCORT)

> **NCT03210545** · PHASE4 · COMPLETED · sponsor: **Göteborg University** · enrollment: 30 (actual)

## Conditions studied

- Addison Disease

## Interventions

- **DRUG:** Betamethasone

## Key facts

- **NCT ID:** NCT03210545
- **Lead sponsor:** Göteborg University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-02
- **Primary completion:** 2021-11-09
- **Final completion:** 2022-02-16
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03210545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03210545, "A Study of Markers of Glucocorticoid Effects in Patients With Addisons Disease (DOSCORT)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03210545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*